This compound is a research reagent characterized by a benzothiazepine core structure with butyl, phenyl, and acetic acid substituents. Its significance lies in its use as a laboratory chemical for investigational studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 439088-13-8
Elobixibat
pharmaceutical raw material
3,3-Dibutyl-8-hydroxy-7-(methylthio)-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepine 1,1-dioxide
pharmaceutical intermediate
7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
research compound
[Rh COD (R)-Binap]BF4
research compound
2,3,4,5,6-Pentafluorobenzyl Alcohol
research compound
6,6'-Dimethyl-2,2'-dipyridyl
research compound
2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,5-benzothiazepin-8-yl)oxy]acetic acid
HLVCNERLDVNLEF-UHFFFAOYSA-N
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)O)SC)C3=CC=CC=C3)CCCC
—